IMFL - ETF AI Analysis
Top Page
Invesco International Developed Dynamic Multifactor ETF (IMFL)
Rating:60Neutral
Price Target:―
Positive Factors
Solid Recent Performance
The ETF has delivered strong gains so far this year and over the past few months, showing positive momentum.
Broad International Diversification
Holdings spread across many developed markets like Japan, the UK, France, Switzerland, and others help reduce reliance on any single country.
Balanced Sector Mix
Exposure across a range of sectors, including industrials, consumer defensive, health care, financials, and energy, helps smooth out sector-specific ups and downs.
Negative Factors
Mixed Top-Holding Performance
Several major positions, such as Roche, Nestlé, 3i Group, Sanofi, and SAP, have shown weak or negative performance this year, which can drag on returns.
Moderate Expense Ratio
The fund’s expense ratio is not especially low, so costs may be higher than some simple index ETFs.
Limited Technology and Communication Exposure
Relatively small weights in technology and communication services mean the fund may benefit less if those growth-oriented sectors lead the market.
IMFL vs. SPDR S&P 500 ETF (SPY)
AUM972.32M
RegionDeveloped Markets
Expense Ratio0.34%
Beta0.70
IssuerInvesco
Inception DateFeb 24, 2021
Dividend Yield2.99%
Asset ClassEquity
Index TrackedFTSE Developed ex US Invesco Dynamic Multifactor Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume18,369
30 Day Avg. Volume189,988
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
37.57Price Target Upside― Downside
Rating ConsensusHold
Number of Analyst Covering801
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IMFL Summary
IMFL is the Invesco International Developed Dynamic Multifactor ETF, which follows the FTSE Developed ex US Invesco Dynamic Multifactor Index. It invests in large, established companies from developed countries outside the U.S., with big positions in places like Japan, the UK, and Europe. Well-known holdings include Novartis, Nestlé, Shell, and SAP. The fund spreads money across many sectors and uses a rules-based approach that looks for stocks with attractive value, steady performance, and lower volatility, which can help with diversification and long-term growth. A key risk is that international stocks can be volatile and move differently from the U.S. market, so the price can go up and down.
How much will it cost me?The Invesco International Developed Dynamic Multifactor ETF (IMFL) has an expense ratio of 0.34%, meaning you’ll pay $3.40 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it uses an actively managed multifactor strategy to optimize returns and manage risk. Passive ETFs typically have lower expense ratios since they track simple indexes without active management.
What would affect this ETF?The IMFL ETF, focused on developed markets outside the U.S., could benefit from positive trends in industrial and financial sectors, which make up a significant portion of its holdings. However, global economic uncertainty, rising interest rates, or unfavorable currency exchange rates could negatively impact its performance, especially given its exposure to international markets. Additionally, regulatory changes or geopolitical tensions in key regions could pose risks to its top holdings like Safran SA and Novartis AG.
IMFL Top 10 Holdings
IMFL’s story is driven by a mix of steady healthcare giants and surging energy names. Novartis and Roche sit near the top, with Novartis quietly rising while Roche has been lagging and acting as a bit of a brake. On the defensive side, Nestlé has been more of a stabilizer than a sprinter. The real horsepower lately comes from Shell and TotalEnergies, both climbing and giving the fund a noticeable energy tilt. With holdings spread across Europe and other developed markets outside the U.S., this ETF is a truly international play.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Novartis AG | 2.76% | $26.54M | CHF207.57B | 22.14% | 80 Outperform | |
| Roche Holding AG | 2.73% | $26.19M | $327.04B | 22.13% | 73 Outperform | |
| Nestlé SA | 2.68% | $25.80M | CHF205.30B | -1.29% | 71 Outperform | |
| Shell (UK) | 2.61% | $25.10M | £184.86B | 32.32% | 73 Outperform | |
| Investor AB | 1.84% | $17.72M | kr1.14T | 30.35% | 77 Outperform | |
| 3i Group plc | 1.43% | $13.77M | £26.75B | -38.04% | 78 Outperform | |
| TotalEnergies SE | 1.39% | $13.35M | €164.70B | 45.23% | 78 Outperform | |
| Sanofi | 1.38% | $13.23M | €96.41B | -9.93% | 75 Outperform | |
| ABB Ltd | 1.25% | $12.05M | CHF140.24B | 78.92% | 78 Outperform | |
| Iberdrola | 1.23% | $11.87M | €133.09B | 29.16% | 67 Neutral |
IMFL Technical Analysis
Positive
―
Price Trends
32.51
Positive
31.69
Positive
29.54
Positive
Market Momentum
0.23
Positive
57.48
Neutral
60.10
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IMFL, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.88, equal to the 50-day MA of 32.51, and equal to the 200-day MA of 29.54, indicating a bullish trend. The MACD of 0.23 indicates Positive momentum. The RSI at 57.48 is Neutral, neither overbought nor oversold. The STOCH value of 60.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IMFL.
IMFL Peer Comparison
Comparison Results
Performance Comparison
IMFL
Invesco International Developed Dynamic Multifactor ETF
33.28
7.65
29.85%
SEIE
SEI Select International Equity ETF
―
―
―
IDHQ
Invesco S&P International Developed High Quality ETF
―
―
―
TLTD
FlexShares Morningstar Developed Markets ex-US Factor Tilt
―
―
―
FYLD
Cambria Foreign Shareholder Yield ETF
―
―
―
TXUE
Thornburg International Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents